Reply

Affiliations

¹ Research Center for Biological Therapy, Beijing 302 Hospital, Beijing, China.
² Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health, Bethesda, MD.

Comment

Zheng Zhang et al. Hepatology. 2016 Jan.

. 2016 Jan;63(1):348.

doi: 10.1002/hep.27879. Epub 2015 Jun 19.

¹ Research Center for Biological Therapy, Beijing 302 Hospital, Beijing, China.
² Laboratory of Liver Diseases, National Institute on Alcohol Abuse and Alcoholism/National Institutes of Health, Bethesda, MD.

No abstract available

Comment on

The global burden of liver disease: the major impact of China.
Wang FS, Fan JG, Zhang Z, Gao B, Wang HY. Wang FS, et al. Hepatology. 2014 Dec;60(6):2099-108. doi: 10.1002/hep.27406. Epub 2014 Oct 29. Hepatology. 2014. PMID: 25164003 Free PMC article. Review.
Contribution of nonignorable environmental factor to impairing liver disease mortality reduction target in China.
Dong C, Peng S. Dong C, et al. Hepatology. 2016 Jan;63(1):347-8. doi: 10.1002/hep.27882. Epub 2015 Jun 19. Hepatology. 2016. PMID: 25953408 No abstract available.